We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Daiichi Sankyo Joins Race to Replace Warfarin with FDA Approval
Daiichi Sankyo Joins Race to Replace Warfarin with FDA Approval
The FDA last week approved Daiichi Sankyo’s new blood thinner to treat certain atrial fibrillation patients based on findings the drug is safer than current treatment warfarin.